Euglycemic DKA ID'd in T2DM Patients With COVID-19
Five cases of euDKA identified in patients with type 2 diabetes using SGLT2 inhibitors who developed SARS-CoV-2 infection
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.